Stephen Kilmer
Contacto de Relaciones con Inversores en HEPION PHARMACEUTICALS, INC. .
Origen de la red de primer grado Stephen Kilmer.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 6 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Stephen Kilmer a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| Seton Hall University | College/University | Undergraduate Degree Masters Business Admin | |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Medical Specialties | Director/Board Member | |
Ciclofilin Pharmaceuticals, Inc.
 Ciclofilin Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Ciclofilin Pharmaceuticals, Inc. develops cyclophilin inhibitors for infectious, inflammatory and degenerative diseases. It offers antiviral drug development, liver disease, viral co-infection, cyclophilin inhibition, macrocycle chemistry and protein folding. The company was founded in 2014 by Robert T. Foster and is headquartered in San Diego, PA. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| Pennsylvania Biotechnology Center of Bucks County | Chief Executive Officer | ||
| Baruch S. Blumberg Institute | Founder | ||
Glycotest, Inc.
 Glycotest, Inc. Electronic Equipment/InstrumentsElectronic Technology Glycotest, Inc. develops diagnostic markers for liver disease diagnosis. It offers disease signal chemistry (glycoprotein fucosylation) present in liver cancers and fibrosis-cirrhosis but absent in healthy individuals. The company was founded in 2012 and is headquartered in New York, NY. | Electronic Equipment/Instruments | Director/Board Member | |
Hatch Biofund Management LLC
 Hatch Biofund Management LLC Investment ManagersFinance Hatch Biofund Management LLC (Hatch Biofund Management) is a venture capital subsidiary of Pennsylvania Biotechnology Center of Bucks County founded in 1900 by Louis P. Kassa and Timothy M. Block. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Founder | |
| University of Alberta | College/University | Doctorate Degree | |
| University of Windsor | College/University | Doctorate Degree | |
| Concordia University | College/University | Graduate Degree | |
| Hepatitis B Foundation | Founder | ||
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
| Mohammed V University | College/University | Doctorate Degree | |
| ESSEC Business School | College/University | Graduate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
| THERALASE TECHNOLOGIES INC. | Medical Specialties | Director/Board Member | |
Steba Biotech SA
 Steba Biotech SA Miscellaneous Commercial ServicesCommercial Services Steba Biotech SA is a Luxembourger biotechnology company that focuses on developing therapies to combat cancer. The private company is based in Luxembourg, Luxembourg. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Drexel University College of Medicine | College/University | Corporate Officer/Principal | |
| STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Vantage Health System, Inc. | Director/Board Member | ||
Accelerated Technologies, Inc.
 Accelerated Technologies, Inc. Medical DistributorsDistribution Services Accelerated Technologies, Inc. creates and accelerates cardiovascular medical devices. The company was founded by Martin B. Leon and Yuval Binur and is headquartered in Hackensack, NJ. | Medical Distributors | Director of Finance/CFO | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
FermaVir Pharmaceuticals LLC
 FermaVir Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FermaVir Pharmaceuticals, Inc. develops pharmaceutical products. The company manufactures compounds for the treatment of varicella zoster virus and chickenpox and human cytomegalovirus. It conducts preclinical trials on FV-100, a prodrug of a compound CF-1743, for the treatment of shingles. FermaVir Pharmaceuticals was founded in December, 2004 and is headquartered in New York City, NY. | Pharmaceuticals: Major | Director/Board Member | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| ELINE ENTERTAINMEN | Movies/Entertainment | Director of Finance/CFO | |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Orchestra Medical Ventures LLC
 Orchestra Medical Ventures LLC Investment ManagersFinance Orchestra Medical Ventures LLC (Orchestra Medical Ventures) is a venture capital firm founded in 2001 by Richard P. Geoffrion and Yuval Binur. The firm is headquartered in New Hope, Pennsylvania. | Investment Managers | Director of Finance/CFO | |
| ACTAVIA LIFE SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| OKYO PHARMA LIMITED | Biotechnology | Director/Board Member | |
| ACCUSTEM SCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TIZIANA LIFE SCIENCES LTD | Pharmaceuticals: Major | Director/Board Member | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
| Iona College | College/University | Undergraduate Degree | |
| IMMUNE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal |
Estadísticas
Internacional
| Estados Unidos | 27 |
| Canadá | 6 |
| Reino Unido | 3 |
| Marruecos | 2 |
| Francia | 2 |
Sectorial
| Health Technology | 18 |
| Consumer Services | 11 |
| Finance | 3 |
| Commercial Services | 3 |
| Electronic Technology | 2 |
Operativa
| Director/Board Member | 17 |
| Independent Dir/Board Member | 11 |
| Director of Finance/CFO | 5 |
| Corporate Officer/Principal | 5 |
| Founder | 4 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| John Brancaccio | 17 |
| Timothy Block | 8 |
| Kaouthar Lbiati | 8 |
| John Cavan | 7 |
| Daren Ure | 3 |
| Daniel Trepanier | 3 |
- Bolsa de valores
- Insiders
- Stephen Kilmer
- Conexiones Empresas
